Advertisement

The Painful Bladder

  • Marko J. Jachtorowycz
Chapter

Abstract

Every physician who provides care to female patients is regularly consulted to evaluate and treat symptoms of pelvic discomfort. These include everything from mild irritation and burning to deep visceral pain. The assessment of the undifferentiated patient with pelvic pain or discomfort calls for an organized system-by-system approach guided by the interview and physical exam findings. Women suffering from bladder pain syndrome or interstitial cystitis (IC/BPS) are frequently among patients presenting with pelvic pain or discomfort. Successful early identification of this subgroup of patients among pelvic pain sufferers is key to mitigating the adverse quality of life impact of bladder pain syndrome (formerly interstitial cystitis).

Keywords

360 degree pelvic examination Bladder pain Dyspareunia Hematuria Interstitial cystitis Overactive bladder Painful bladder syndrome Pelvic pain Pentosan polysulfate PUF questionnaire Vestibulitis Vulvodynia 

References

  1. 1.
    Parsons CL, Dell J, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60:573–8.CrossRefGoogle Scholar
  2. 2.
    Clemens JQ, Joyce GF, Wise M, Payne C. Interstitial cystitis and painful bladder syndrome. In: Litwin MS, Saigal CS, editors. Urologic diseases in America. Washington: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007. p. 123.Google Scholar
  3. 3.
    Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109:1584–91.CrossRefGoogle Scholar
  4. 4.
    Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, Chey WY. Gastroenterology. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hosp Incidence. 1990;98(1):104–10.Google Scholar
  5. 5.
    Hohenfellner M, Nunes L, et al. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol. 1992;147:587–91.CrossRefGoogle Scholar
  6. 6.
    Parsons CL, Greenberger M, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol. 1998;159:1862–7.CrossRefGoogle Scholar
  7. 7.
    Simon LJ, Landis JR, Erickson DR, Nyberg LM. The interstitial cystitis data base study: concepts and preliminary baseline descriptive statistics. Urology. 1997;49(5A Suppl):64–75.CrossRefGoogle Scholar
  8. 8.
    Minaglia S, Ozel B, Bizhang R, Mishell DR Jr. Interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California. Urology. 2005;66:702–6.CrossRefGoogle Scholar
  9. 9.
    Parsons CL. Argument for the use of the potassium sensitivity test in the diagnosis of interstitial cystitis. For. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(6):430–1.CrossRefGoogle Scholar
  10. 10.
    Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg L Jr, Payne CK, Wesselmann U, Faraday MM. Interstitial Cystitis Guidelines Panel of the American Urological Association Education and Research, Inc., AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.CrossRefGoogle Scholar
  11. 11.
    Kushner L, Moldwin RM. Efficiency of questionnaires used to screen for interstitial cystitis. J Urol. 2006;176:587–92.CrossRefGoogle Scholar
  12. 12.
    Rossberger MF, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome J. Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden. Scand J Urol Nephrol. 2005;39:73–7.CrossRefGoogle Scholar
  13. 13.
    Peeker R, Haghsheno MA, Holmang S, et al. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis:a prospective, randomized double-blind study. J Urol. 2000;164:1912–6.CrossRefGoogle Scholar
  14. 14.
    Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosanpolysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology. 1990;35:552–8.CrossRefGoogle Scholar
  15. 15.
    Parsons CL, Benson G, Childs SJ, Hanna P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol. 1993;150:845–8.CrossRefGoogle Scholar
  16. 16.
    Holm-Bentzen M, Jacobsen F, Nerstrom B, Lose G, Kristensen JK, Pedersen RH. A prospective double blind clinically controlled multicentre trial of sodium pentosan polysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol. 1987;138:503–7.CrossRefGoogle Scholar
  17. 17.
    Philip M. Analysis of long-term Elmiron therapy for interstitial cystitis. Hanno Urol. 1997;49(5, Supplement 1):93–9.CrossRefGoogle Scholar
  18. 18.
    Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology. 1997;49 (5A suppl):93–9.CrossRefGoogle Scholar
  19. 19.
    Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49(5A Suppl):108–10.CrossRefGoogle Scholar
  20. 20.
    van Ophoven A, Pokupic S, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533–6.CrossRefGoogle Scholar
  21. 21.
    Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol. 2009; 16:4536.Google Scholar
  22. 22.
    Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, Cruz C, Cruz F, Dinis P. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58(3):360–5. Epub 2010 Mar 6.CrossRefGoogle Scholar
  23. 23.
    Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169:1369–73.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical EducationPresence Saint Francis HospitalEvanstonUSA

Personalised recommendations